Abstract:Autophagy plays an important role in pressure overload-induced cardiac hypertrophy. Tanshinol borneol ester (DBZ), which is a combination of Dan Shen abstract and borneol, has been proved to be effective in attenuating various cardiovascular diseases. However, whether the effect of DBZ in attenuating cardiac hypertrophy is through regulation of autophagy is unknown. In this study, we investigated the effect of DBZ both in vitro and in vivo. Neonatal rat ventricular myocytes (NRCMs) were cultured to test the effect of DBZ in vitro, and transverse aortic coarctation (TAC) was performed in rats for in vivo study. Results demonstrated that DBZ reduced the size of heart, genes and proteins expression of hypertrophic markers, ROS generation, cellular stress, remodeling and ameliorated the function of left ventricular. Moreover, autophagy was significantly decreased, indicating that DBZ may improve cardiac hypertrophy by inhibiting autophagy. Finally, our results showed that DBZ regulates autophagy via mTOR/p70S6K and ERK1/2 rather than the p38 pathway. In conclusion, these results suggest that DBZ can attenuate cardiac hypertrophy through inhibiting autophagy via mTOR/p70S6K and ERK1/2 pathway.Funding Statement: This work was supported by grants from the National Natural Science Foundation of China (81873493 to D.S.), Science and technology innovation personnel of the Education Department of Henan Province (19HASTIT002 to D.S.), Science and Technology Leading Talents of Health Commission of Henan Province (51282 project, 100 to D.S.) 5451 Project of Henan Provincial Commission of Health and Family Planning (2015002 to D.S.). Additional support from the University-College Joint Cultivation Fund of Zheng Zhou University (2016-BSTDJJ-19), Henan Province’s Key Laboratory of Cardiac Injury and Repair. Declaration of Interests: All authors have no competing interests to declare, financial or otherwise.Ethics Approval Statement: All experimental protocols were approved by the Animal Research Center of Zheng Zhou University and conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 8523, revised 1996).

A Novel Compound, Tanshinol Borneol Ester, Ameliorates Pressure Overload-Induced Cardiac Hypertrophy by Inhibiting Oxidative Stress Via the Mtor/β-Trcp/nrf2 Pathway

Tanshinol Borneol Ester Improves Pressure Overload-Induced Cardiac Hypertrophy Through Mitigating Autophagy

Thymoquinone Ameliorates Pressure Overload‐induced Cardiac Hypertrophy by Activating the AMPK Signalling Pathway

RTA 408 Ameliorates Diabetic Cardiomyopathy by Activating Nrf2 to Regulate Mitochondrial Fission and Fusion and Inhibiting NF-κB-mediated Inflammation.

Tanshinol Borneol Ester, a Novel Synthetic Small Molecule Angiogenesis Stimulator Inspired by Botanical Formulations for Angina Pectoris

Tamarixetin Protects Against Cardiac Hypertrophy Via Inhibiting NFAT and AKT Pathway

The anti-atherosclerotic effect of tanshinol borneol ester using fecal metabolomics based on liquid chromatography-mass spectrometry

LCZ696 Ameliorates Oxidative Stress and Pressure Overload-Induced Pathological Cardiac Remodeling by Regulating the Sirt3/MnSOD Pathway

Tetrandrine Blocks Cardiac Hypertrophy by Disrupting Reactive Oxygen Species-Dependent Erk1/2 Signalling

Rosuvastatin improves myocardial hypertrophy after hemodynamic pressure overload via regulating the crosstalk of Nrf2/ARE and TGF-β/ smads pathways in rat heart

Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.

Beta3-Adrenergic Receptor Activation Alleviates Cardiac Dysfunction in Cardiac Hypertrophy by Regulating Oxidative Stress.

Antrodia Cinnamomea Triterpenoids Attenuate Cardiac Hypertrophy Via the SNW1/RXR/ALDH2 Axis

Inhibition of Cardiac Hypertrophy by Aromadendrin Through Down-Regulating NFAT and MAPKs Pathways.

Shensongyangxin protects against pressure overload‑induced cardiac hypertrophy

Protective effects of tannic acid on pressure overload-induced cardiac hypertrophy and underlying mechanisms in rats.

Tanshinone I Inhibits Oxidative Stress–Induced Cardiomyocyte Injury by Modulating Nrf2 Signaling

Tanshinone Iia Protects Against Cardiac Hypertrophy Via Inhibiting Calcineurin/Nfatc3 Pathway

Schisandrin B attenuates pressure overload‑induced cardiac remodeling in mice by inhibiting the MAPK signaling pathway

Cardioprotective Effects of Tanshinone IIA Pretreatment Via Kinin B2 Receptor-Akt-gsk-3β Dependent Pathway in Experimental Diabetic Cardiomyopathy

Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity.